A Study to Test the Use of the E-PAL Mobile Application for Pain Management in Cancer Patients
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-002638
NCT ID: NCT02069743
Sponsor Protocol Number: 13-080
About this study
The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. The purpose of this study is to evaluate the effect of this mobile-based intervention. The intent is that subjects will achieve greater reductions in cancer-related pain and improved quality of life.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- 18 years and older
- Has solid-organ cancer
- Diagnosed with moderate or severe cancer pain
- Pain intensity score of at least 4/10 on numeric rating scale at Massachusetts General Hospital Palliative Care Center
- Determined by the patient's care provider
- Do not need to experience a specific nature of pain
- Must be ambulatory and not currently admitted to the hospital at time of enrollment
- For phase II, must have a smart phone and be willing to download the study application
- Must be able to read and speak English
Exclusion Criteria
- A life expectancy of less than 2-months as determined by the palliative care provider
- Significant medical or psychiatric co-morbidities (other than depression or anxiety) or cognitive impediments that would prevent participant from being able to utilize the program
- Known history of substance abuse
- Currently on investigational therapies or other study protocols that may have an impact on pain intensity or quality of life which are main outcomes of this intervention
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Jacob Strand, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available